These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15480433)

  • 21. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers.
    Nosho K; Yamamoto H; Takahashi T; Mikami M; Taniguchi H; Miyamoto N; Adachi Y; Arimura Y; Itoh F; Imai K; Shinomura Y
    Carcinogenesis; 2007 Jun; 28(6):1364-70. PubMed ID: 17183069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
    Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
    Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients.
    Chan MW; Chan LW; Tang NL; Lo KW; Tong JH; Chan AW; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
    Int J Cancer; 2003 May; 104(5):611-6. PubMed ID: 12594816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
    Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
    Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis.
    Menigatti M; Pedroni M; Verrone AM; Borghi F; Scarselli A; Benatti P; Losi L; Di Gregorio C; Schär P; Marra G; Ponz de Leon M; Roncucci L
    Oncol Rep; 2007 Jun; 17(6):1421-7. PubMed ID: 17487400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of RASSF1a in uveal melanoma.
    Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue sampling for mutation analysis in colorectal cancer: K-ras is homogeneously distributed throughout the tumor tissue.
    Ekelund S; Papadogiannakis N; Olivecrona H; Lindforss U
    Oncol Rep; 2011 Jan; 25(1):253-8. PubMed ID: 21109984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
    Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma.
    Li J; El-Naggar A; Mao L
    Cancer; 2005 Aug; 104(4):771-6. PubMed ID: 15959912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers.
    Destro A; Bianchi P; Alloisio M; Laghi L; Di Gioia S; Malesci A; Cariboni U; Gribaudi G; Bulfamante G; Marchetti A; Bosari S; Infante M; Ravasi G; Roncalli M
    Lung Cancer; 2004 Apr; 44(1):23-32. PubMed ID: 15013580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
    Miranda E; Destro A; Malesci A; Balladore E; Bianchi P; Baryshnikova E; Franchi G; Morenghi E; Laghi L; Gennari L; Roncalli M
    Br J Cancer; 2006 Oct; 95(8):1101-7. PubMed ID: 16969349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
    Sakai Y; Yanagisawa A; Shimada M; Hidaka E; Seki M; Tada Y; Harada T; Saisho H; Kato Y
    Hum Pathol; 2000 Jul; 31(7):795-803. PubMed ID: 10923915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
    Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
    Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
    Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
    Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue.
    Peters I; Vaske B; Albrecht K; Kuczyk MA; Jonas U; Serth J
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2526-32. PubMed ID: 18086755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.
    Wang Y; Yu Z; Wang T; Zhang J; Hong L; Chen L
    Lung Cancer; 2007 May; 56(2):289-94. PubMed ID: 17267069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.